Title
Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial
Publication Date
2022
Content Type
Article
PubMed ID:
Citation
Neuro-Oncology (2022) [Epub ahead of print] Published online: July 15